Clinical Trials
We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally.
The PICKUP Study
Complete Title: Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens (PICKUP)
PRINCIPAL INVESTIGATOR: JOSHUA HILL | PHASE: N/A
The RAVCAR Study
Complete title: Rabies Vaccination to Assess Vaccine Responsiveness after B Cell Targeted CAR-T Cell Therapies
PRINCIPAL INVESTIGATOR: JOSHUA HILL | PHASE: I
Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19
Complete title: A Phase 1 Study of DVX201, an Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19
PRINCIPAL INVESTIGATOR: JOSHUA HILL | PHASE: I
Study to Evaluate Viralym-M (ALVR105) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant
Complete Title: Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Viralym-M Compared to Placebo for the Prevention of AdV, BKV, CMV, EBV, HHV-6, and JCV Infection and/or Disease, in High-Risk Patients After Allogeneic Hematopoietic Cell Transplant
PRINCIPAL INVESTIGATOR: JOSHUA HILL | PHASE: II
Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)
Complete Title: Phase 3 Multicenter, Double-Blind, Placebo-Controlled Trial of Viralym-M (ALVR105) for the Treatment of Patients With Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplant (HCT)
PRINCIPAL INVESTIGATOR: JOSHUA HILL | PHASE: III
© 2023 Fred Hutchinson Cancer Center, a 501(c)(3) nonprofit organization.